Patent · US Expired

Heteroaryloxy-substituted phenylaminopyrimidines as rho-kinase inhibitors

US7737153B2 · kind B2 · utility

9Cited by

0References

6Claims

0Family size

Assignee

Bayer Schering Pharma AG · DE

Inventors

Achim Feurer · Wilhelmsfeld, DE
Samir Bennabi · Wuppertal, DE
Heike Heckroth · Wuppertal, DE
Hartmut Schirok · Wuppertal, DE
Joachim Mittendorf · Wuppertal, DE
Raimund Kast · Wuppertal, DE
Johannes-Peter Stasch · Wuppertal, DE
Jean Mark Gnoth · Mettmann, DE
Klaus Münter · Mannheim, DE
Dieter Lang · Velbert, DE
Santiago Figueroa Perez · Leverkusen, DE
Heimo Ehmke · Hamburg, DE

Key dates

Filing date	Oct 16, 2003
Grant date	Jun 15, 2010
Priority date	—
Expiry date	Nov 4, 2023

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D471/04
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

The invention relates to heteroaryloxy-substituted phenylaminopyrimidines, to methods for the production thereof, and to the use of the same for producing medicaments for the treatment and/or prophylaxis of diseases, especially cardiovascular diseases. The inventive compounds inhibit Rho-Kinase.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.